{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:52Z","timestamp":1792103872988,"version":"4.4.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Polyvascular disease (PolyVD) and interleukin (IL)-6 are associated with poor outcomes in patients with stroke respectively. However, whether combined PolyVD and elevated IL-6 levels would increase the risk of poor outcomes of stroke patients is yet unclear.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Data were obtained from the Third China National Stroke Registry (CNSR-III). PolyVD was defined as acute ischemic stroke (AIS) or transient ischemic attack (TIA) with coronary artery disease (CAD) and\/or peripheral artery disease (PAD). Patients were divided into four groups according to the combination of vascular beds number (non-PolyVD or PolyVD) and IL-6 levels (IL-6 &amp;lt; 2.64 pg\/mL or IL-6 \u2265 2.64 pg\/mL). The primary outcome was a recurrent stroke at 1-year follow-up. Cox proportional hazard models were employed to identify the association of the combined effect of PolyVD and IL-6 with the prognosis of patients.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 10,773 patients with IL-6 levels and 1-year follow-up were included. The cumulative incidence of recurrent stroke was 9.87% during the 1-year follow-up. Compared to non-PolyVD and IL-6&amp;lt;2.64 pg\/mL patients, patients had non-PolyVD with IL-6 \u2265 2.64 pg\/mL (HR 1.245 95%CI 1.072\u20131.446; <jats:italic>P<\/jats:italic> &amp;lt; 0.001) and PolyVD with IL-6 &amp;lt;2.64 pg\/mL (HR 1.251 95%CI 1.002\u20131.563; <jats:italic>P<\/jats:italic> = 0.04) were associated with an increased risk of recurrent stroke during 1-year follow-up. Likewise, patients with PolyVD and IL-6 \u2265 2.64 pg\/mL (HR 1.290; 95% CI 1.058\u20131.572; <jats:italic>P<\/jats:italic> = 0.01) had the highest risk of recurrent stroke at 1-year follow-up among groups.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> PolyVD and elevated IL-6 levels are both associated with poor outcomes in patients with AIS or TIA. Moreover, the combination of them increases the efficiency of stroke risk stratification compared with when used alone. More attention and intensive treatment should be given to those patients with both PolyVD and elevated IL-6 levels.<\/jats:p>","DOI":"10.3389\/fneur.2021.661779","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T05:03:41Z","timestamp":1618290221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of Polyvascular Disease and Elevated Interleukin-6 With Outcomes in Acute Ischemic Stroke or Transient Ischemic Attack"],"prefix":"10.3389","volume":"12","author":[{"given":"Ye","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Collaborators","year":"2017","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the american heart association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S1474-4422(18)30500-3","article-title":"Stroke in China: advances and challenges in epidemiology, prevention, and management","volume":"18","author":"Wu","year":"2019","journal-title":"Lancet Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/svn-2020-000457","article-title":"China stroke statistics 2019: a report from the national center for healthcare quality management in neurological diseases, china national clinical research center for neurological diseases, the chinese stroke association, national center for chronic and non-communicable disease control and prevention, chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations","volume":"5","author":"Wang","year":"2020","journal-title":"Stroke Vasc Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1474-4422(09)70023-7","article-title":"Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling","volume":"8","author":"Johnston","year":"2009","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","article-title":"Five-year risk of stroke after TIA or minor ischemic stroke","volume":"378","author":"Amarenco","year":"2018","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/bc.bc_36_18","article-title":"Treatment for ischemic stroke: from thrombolysis to thrombectomy and remaining challenges","volume":"5","author":"Leng","year":"2019","journal-title":"Brain Circ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e007385","DOI":"10.1161\/CIRCINTERVENTIONS.119.007385","article-title":"Polyvascular disease: reappraisal of the current clinical landscape","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Circ Cardiovasc Interv."},{"key":"B12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1177\/1358863x10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry","volume":"15","author":"Suarez","year":"2010","journal-title":"Vascu Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrneurol.2016.125","article-title":"Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke","volume":"12","author":"Esenwa","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/CRD.0000000000000021","article-title":"Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy","volume":"22","author":"Hartman","year":"2014","journal-title":"Cardiol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1747-4949.2009.00396.x","article-title":"Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke\/transient ischaemic attack","volume":"5","author":"Shenhar-Tsarfaty","year":"2010","journal-title":"Int J Stroke."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1373\/clinchem.2016.269969","article-title":"Prognostic value of inflammatory and cardiovascular biomarkers for prediction of 90-day all-cause mortality after acute ischemic stroke-results from the linz stroke unit study","volume":"63","author":"Dieplinger","year":"2017","journal-title":"Clin Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12883-019-1375-6","article-title":"Biomarkers of immune capacity, infection and inflammation are associated with poor outcome and mortality after stroke - the PREDICT study","volume":"19","author":"Mengel","year":"2019","journal-title":"BMC Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/svn-2019-000242","article-title":"The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics","volume":"4","author":"Wang","year":"2019","journal-title":"Stroke Vasc Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/svn-2020-000576","article-title":"Inconsistent centralised versus non-centralised ischaemic stroke aetiology","volume":"5","author":"Suo","year":"2020","journal-title":"Stroke Vasc Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1331\/154434504322904569","article-title":"Atherothrombosis: epidemiology, pathophysiology, and prevention","volume":"44","author":"Munger","year":"2003","journal-title":"J Am Pharm Assoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","article-title":"Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes","volume":"30","author":"Bhatt","year":"2009","journal-title":"Eur Heart J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e185239","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial","volume":"1","author":"Gutierrez","year":"2018","journal-title":"JAMA Netw Open."},{"key":"B24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.atherosclerosis.2009.07.041","article-title":"Stroke with polyvascular atherothrombotic disease","volume":"208","author":"Blanco","year":"2010","journal-title":"Atherosclerosis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000335833","article-title":"Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke: findings of the SIRIO study","volume":"33","author":"Cimminiello","year":"2012","journal-title":"Cerebrovasc Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000120687","article-title":"Risk factor profile and management of cerebrovascular patients in the REACH Registry","volume":"25","author":"Rother","year":"2008","journal-title":"Cerebrovasc Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA."},{"key":"B28","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/pcad.2002.123472","article-title":"Plaque instability in peripheral vessels","volume":"44","author":"Silva","year":"2002","journal-title":"Prog Cardiovasc Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1161\/STROKEAHA.113.003657","article-title":"Plaque inflammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis","volume":"45","author":"Marnane","year":"2014","journal-title":"Stroke."},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jjcc.2018.05.010","article-title":"Critical roles of inflammation in atherosclerosis","volume":"73","author":"Moriya","year":"2019","journal-title":"J Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1042\/CS20130284","article-title":"Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke","volume":"126","author":"Tu","year":"2014","journal-title":"Clin Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1161\/01.STR.0000079815.38626.44","article-title":"Multiple levels of regulation of the interleukin-6 system in stroke","volume":"34","author":"Acalovschi","year":"2003","journal-title":"Stroke."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.021","article-title":"Infarction size, interleukin-6, and their interaction are predictors of short-term stroke outcome in young egyptian adults","volume":"25","author":"Fahmi","year":"2016","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11011-019-00403-6","article-title":"Immune-inflammatory, oxidative stress and biochemical biomarkers predict short-term acute ischemic stroke death","volume":"34","author":"Reiche","year":"2019","journal-title":"Metab Brain Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.5114\/aoms.2015.52352","article-title":"Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease","volume":"11","author":"Koyama","year":"2015","journal-title":"Arch Med Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e005077","DOI":"10.1161\/JAHA.116.005077","article-title":"Inflammatory biomarkers interleukin-6 and c-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib therapy) trial","volume":"6","author":"Held","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s0140-6736(99)04470-0","article-title":"Evidence of a chronic systemic cause of instability of atherosclerotic plaques","volume":"355","author":"Rothwell","year":"2000","journal-title":"Lancet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jneuroim.2014.07.015","article-title":"Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis","volume":"274","author":"Bustamante","year":"2014","journal-title":"J Neuroimmunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"544","DOI":"10.14336\/AD.2018.0820","article-title":"The prognostic value of serum cytokines in patients with acute ischemic stroke","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661779\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T05:03:42Z","timestamp":1618290222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.661779\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":40,"alternative-id":["10.3389\/fneur.2021.661779"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.661779","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"article-number":"661779"}}